Eligibility criteria
Condition
Hypertension
Sex
Females and Males
Age
20-79 years
Inclusion criteria
Show details
- Patients who had completed the preceding study A0531085, Phase III study, who the
investigator judged to be able to further treatment of long term administration in
terms of efficacy and safety
- Patients who had a treatment compliance rate of at least 80%
Exclusion criteria
Show details
- The patient who met the discontinuation criteria in the preceding study A0531085